Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Paula S. Piraino"'
Autor:
Allan Gordon, Saifudin Rashiq, Dwight E Moulin, Alexander J Clark, André D Beaulieu, John Eisenhoffer, Paula S Piraino, Patricia Quigley, Zoltan Harsanyi, Andrew C Darke
Publikováno v:
Pain Research and Management, Vol 15, Iss 3, Pp 169-178 (2010)
OBJECTIVE: The present randomized, double-blinded, crossover study compared the efficacy and safety of a seven-day buprenorphine transdermal system (BTDS) and placebo in patients with low back pain of moderate or greater severity for at least six wee
Externí odkaz:
https://doaj.org/article/c00209049ee440d48f64a49bf97d0ec8
Autor:
Carter Thorne, André D Beaulieu, Denis J Callaghan, William F O’Mahony, John M Bartlett, Richard Knight, Gunnar R Kraag, Ronald Akhras, Paula S Piraino, John Eisenhoffer, Zoltan Harsanyi, Andrew C Darke
Publikováno v:
Pain Research and Management, Vol 13, Iss 2, Pp 93-102 (2008)
OBJECTIVE: To compare the efficacy and safety of controlled-release (CR) tramadol (Zytram XL, Purdue Pharma, Canada) and placebo in patients with painful osteoarthritis.
Externí odkaz:
https://doaj.org/article/d22a843631d5440fba8cc5a471625dc8
Autor:
John Taliano, L Robinson, John Eisenhoffer, Zoltan Harsanyi, M Awde, William F O’Mahony, Paula S. Piraino, S Henein, D Sinclair, G Cohen, Kenneth J. Michalko, I Sutton, M Csanadi, C Cloutier
Publikováno v:
Pain Research and Management, Vol 18, Iss 2, Pp 75-82 (2013)
BACKGROUND: For Canadian regulatory purposes, an analgesic study was required to complement previously completed, pivotal studies on bowel effects and analgesia associated with controlled-release (CR) oxycodone/CR naloxone.OBJECTIVES: To compare the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a7c41352f304175c2493c72228fc71c
https://doi.org/10.1155/2013/164609
https://doi.org/10.1155/2013/164609
Autor:
Zoltan Harsanyi, Carter Thorne, André D. Beaulieu, Gunnar R Kraag, Richard Knight, Denis J Callaghan, Ronald Akhras, John Eisenhoffer, Andrew C. Darke, John M Bartlett, Paula S. Piraino, William F O’Mahony
Publikováno v:
Pain Research and Management, Vol 13, Iss 2, Pp 93-102 (2008)
OBJECTIVE: To compare the efficacy and safety of controlled-release (CR) tramadol (Zytram XL, Purdue Pharma, Canada) and placebo in patients with painful osteoarthritis.METHODS: Patients underwent analgesic washout for two to seven days before random
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16e20f12e11751842d44aeb2ae1f6e8e
https://doi.org/10.1155/2008/165421
https://doi.org/10.1155/2008/165421
Autor:
Saifudin Rashiq, Paula S. Piraino, Dwight E. Moulin, Allan Gordon, Patricia Quigley, John Eisenhoffer, Andrew C. Darke, Zoltan Harsanyi, Alexander J. Clark, André D. Beaulieu
Publikováno v:
Pain Research and Management, Vol 15, Iss 3, Pp 169-178 (2010)
OBJECTIVE: The present randomized, double-blinded, crossover study compared the efficacy and safety of a seven-day buprenorphine transdermal system (BTDS) and placebo in patients with low back pain of moderate or greater severity for at least six wee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a08ee67864445f2fb202300182e38485
https://pubmed.ncbi.nlm.nih.gov/20577660
https://pubmed.ncbi.nlm.nih.gov/20577660
Autor:
James Kim, John Eisenhoffer, William F O’Mahony, Zoltan Harsanyi, Paula S. Piraino, Norm Buckley, Andrew C. Darke, Aline Boulanger, Saifudin Rashiq, Allan Gordon, Denis J.G. Callaghan, Geoffrey Cohen, Donald Spink, Duncan Sinclair, Kenneth J. Michalko, Peter Dzongowski, Christian Cloutier
Publikováno v:
Clinical therapeutics. 32(5)
Background: Buprenorphine is a mixed-activity, partial μ-opioid agonist. Its lipid solubility makes it well suited for transdermal administration. Objective: This study assessed the efficacy and safety profile of a 7-day buprenorphine transdermal sy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e553d92c9db2dc8193fdaa49f7764806
https://pubmed.ncbi.nlm.nih.gov/20685494
https://pubmed.ncbi.nlm.nih.gov/20685494
Autor:
Andrew C. Darke, Zoltan Harsanyi, John Eisenhoffer, Paul Peloso, Jacqueline Gardner-Nix, Glen T. D. Thomson, André D. Beaulieu, William G. Bensen, Alexander J. Clark, C. Peter N. Watson, Paula S. Piraino
Publikováno v:
Clinical therapeutics. 29(1)
The purpose of this study was to evaluate the efficacy of controlled-release (CR) tramadol and immediate-release (IR) tramadol in patients with moderate or greater intensity chronic noncancer pain.A total of 122 patients underwent washout from all op
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::139a16b5c6201cd7a636d6edd1e13eb1
https://pubmed.ncbi.nlm.nih.gov/17379046
https://pubmed.ncbi.nlm.nih.gov/17379046